Swiss Helvetia Fund, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-Q
QUARTERLY SCHEDULE OF
PORTFOLIO HOLDINGS OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-05128
THE SWISS HELVETIA FUND, INC.
1270 Avenue of the Americas, Suite 400
New York, New York 10020
1-888-SWISS-00
Rodolphe E. Hottinger, President
Hottinger et Cie
3 Place des Bergues
C.P. 395
CH-1201 Geneva
Switzerland
Date of fiscal year end: December 31
Date of reporting period: July 1, 2008 - September 30, 2008
Item 1. Schedule of Investments.
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited) |
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks 83.51% |
|
|
|
|
|
|
|
|
|
Banks 2.75% |
|
|
|
|
|
|
|
|
|
|
20,407 |
|
Bank Sarasin & Cie AG Registered Shares |
|
$ |
778,060 |
|
0.16 |
% |
|
|
Offers private banking, asset management, investment advisory, and institutional banking services. (Cost $764,604) |
|
|
|
|
|
|
|
|
|
|
172,500 |
|
Credit Suisse Group1 Registered Shares |
|
|
7,676,923 |
|
1.52 |
% |
|
|
A global diversified financial service company with significant activity in private banking, investment banking, asset management and insurance service. (Cost $4,523,886) |
|
|
|
|
|
|
|
|
|
|
329,075 |
|
UBS AG1,2 Registered Shares |
|
|
5,417,814 |
|
1.07 |
% |
|
|
A global diversified financial service company with significant activity in private banking, investment banking, and asset management. (Cost $2,242,403) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,872,797 |
|
2.75 |
% |
|
|
|
Basic Resources 0.58% |
|
|
|
|
|
|
|
|
|
|
26,236 |
|
Precious Woods Holding AG2 Registered Shares |
|
|
1,790,015 |
|
0.35 |
% |
|
|
Through subsidiaries, manages tropical forests using ecologically sustainable forest management methods. Harvests tropical trees and processes them into lumber. (Cost $2,107,307) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
Basic Resources (continued) |
|
|
|
|
|
|
|
75,000 |
|
UMS Schweizerische Metallwerke Holding AG2 Bearer Shares |
|
$ |
1,150,501 |
|
0.23 |
% |
|
|
Produces profiles and large dimension rods for electrical engineering, mechanical engineering, and construction companies, lead-free brass wire for batteries, billets and small diameter wire
and rods for the consumer goods and electronics industries. (Cost $1,655,850) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,940,516 |
|
0.58 |
% |
|
|
|
Biotechnology 9.96% |
|
|
|
|
|
|
|
|
|
|
124,655 |
|
Actelion, Ltd.1,2 Registered Shares |
|
|
6,348,094 |
|
1.26 |
% |
|
|
Biotechnology company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. (Cost $1,815,945) |
|
|
|
|
|
|
|
|
|
|
314,860 |
|
Addex Pharmaceuticals, Ltd.2 Registered Shares |
|
|
13,198,145 |
|
2.61 |
% |
|
|
Bio-pharmaceutical company that discovers, develops, and markets therapeutic compounds for the treatment of addiction and other neuropsychiatric conditions. (Cost $16,016,264) |
|
|
|
|
|
|
|
|
|
|
10,000 |
|
Bachem Holding AG Registered Shares |
|
|
789,298 |
|
0.16 |
% |
|
|
Manufactures ingredients for pharmaceuticals, generic drugs, and research supplies. (Cost $833,329) |
|
|
|
|
|
|
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited) (continued) |
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks (continued) |
|
|
|
|
|
|
|
|
Biotechnology (continued) |
|
|
|
|
|
|
|
131,250 |
|
Basilea Pharmaceutica1,2 Registered Shares |
|
$ |
19,314,381 |
|
3.83 |
% |
|
|
Conducts research into the development of drugs for the treatment of infectious diseases and dermatological problems. (Cost $18,117,602) |
|
|
|
|
|
|
|
|
|
|
10,000 |
|
Santhera Pharmaceuticals2 Registered Shares |
|
|
397,324 |
|
0.08 |
% |
|
|
Drug discovery and development company. (Cost $948,284) |
|
|
|
|
|
|
|
|
|
|
81,903 |
|
Speedel Holding AG2 Registered Shares |
|
|
10,219,157 |
|
2.02 |
% |
|
|
Researches and develops therapies for cardiovascular and metabolic diseases. (Cost $10,812,921) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,266,399 |
|
9.96 |
% |
|
|
|
Chemicals 4.94% |
|
|
|
|
|
|
|
|
|
|
117,931 |
|
Syngenta AG1 Registered Shares |
|
|
24,948,257 |
|
4.94 |
% |
|
|
Produces herbicides, insecticides and fungicides, and seeds for field crops, vegetables, and flowers. (Cost $12,466,047) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,948,257 |
|
4.94 |
% |
|
|
|
Construction & Materials 0.20% |
|
|
|
|
|
|
|
|
|
|
1,141 |
|
Belimo Holding AG Registered Shares |
|
|
1,007,438 |
|
0.20 |
% |
|
|
World market leader in damper and volume control actuators for ventilation and air-conditioning equipment. (Cost $222,726) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,007,438 |
|
0.20 |
% |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
|
Food & Beverages 18.88% |
|
|
|
|
|
|
|
|
|
|
2,690 |
|
Barry Callebaut AG Registered Shares |
|
$ |
1,611,001 |
|
0.32 |
% |
|
|
Manufactures cocoa, chocolate, and confectionary products. (Cost $1,374,087) |
|
|
|
|
|
|
|
|
|
|
290 |
|
Lindt & Sprungli AG Registered Shares |
|
|
7,823,857 |
|
1.55 |
% |
|
|
Major manufacturer of premium Swiss chocolates. (Cost $1,141,585) |
|
|
|
|
|
|
|
|
|
|
1,997,000 |
|
Nestle SA1 Registered Shares |
|
|
85,846,511 |
|
17.01 |
% |
|
|
Largest food and beverage processing company in the world. (Cost $27,020,121) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95,281,369 |
|
18.88 |
% |
|
|
|
Industrial Goods & Services 2.07% |
|
|
|
|
|
|
|
|
|
|
446,457 |
|
ABB, Ltd. Registered Shares |
|
|
8,409,518 |
|
1.67 |
% |
|
|
The holding company for ABB Group, which is one of the largest electrical engineering firms in the world. (Cost $4,789,336) |
|
|
|
|
|
|
|
|
|
|
6,440 |
|
Inficon Holding AG Registered Shares |
|
|
712,205 |
|
0.14 |
% |
|
|
Manufactures and markets vacuum instruments used to monitor and control production processes. Manufactures on-site chemical detection and monitoring system. (Cost $581,616) |
|
|
|
|
|
|
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited) (continued) |
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks (continued) |
|
|
|
|
|
Industrial Goods & Services (continued) |
|
|
|
|
|
|
|
11,648 |
|
Komax Holding AG Registered Shares |
|
$ |
1,297,512 |
|
0.26 |
% |
|
|
Manufactures wire processing machines. Produces machines for cutting and tripping round and flat wire, crimping and insertion machines for processing single wires and equipment for processing
wire harnesses. (Cost $1,789,079) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,419,235 |
|
2.07 |
% |
|
|
|
Insurance 7.71% |
|
|
|
|
|
|
|
|
|
|
28,000 |
|
Baloise Holding AG Registered Shares |
|
|
1,877,904 |
|
0.37 |
% |
|
|
Offers group and individual life, health, accident, liability, property and transportation insurance (Cost $2,095,588) |
|
|
|
|
|
|
|
|
|
|
180,000 |
|
Swiss Re Registered Shares |
|
|
9,744,481 |
|
1.93 |
% |
|
|
Offers reinsurance and insurance linked financial market products (Cost $11,038,198) |
|
|
|
|
|
|
|
|
|
|
100,000 |
|
Zurich Financial Services AG Registered Shares |
|
|
27,290,970 |
|
5.41 |
% |
|
|
Offers property, accident, health, automobile, liability, financial risk and life insurance and retirement products. (Cost $26,057,885) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,913,355 |
|
7.71 |
% |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
|
Medical Technology 0.98% |
|
|
|
|
|
|
|
|
|
|
150,000 |
|
Nobel Biocare Holding AG Registered Shares |
|
$ |
4,957,860 |
|
0.98 |
% |
|
|
Develops and produces dental implants and dental prosthetics (Cost $5,265,016) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,957,860 |
|
0.98 |
% |
|
|
|
Personal & Household Goods 0.15% |
|
|
|
|
|
|
|
|
|
|
14,972 |
|
Schulthess Group Registered Shares |
|
|
754,442 |
|
0.15 |
% |
|
|
Develops, manufactures, and sells household appliances and heating equipment. (Cost $1,200,040) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
754,442 |
|
0.15 |
% |
|
|
|
Pharmaceuticals 21.46% |
|
|
|
|
|
|
|
|
|
|
891,300 |
|
Novartis AG1 Registered Shares |
|
|
46,542,355 |
|
9.23 |
% |
|
|
One of the leading manufacturers of branded and generic pharmaceutical products. Manufactures nutrition products. (Cost $14,613,905) |
|
|
|
|
|
|
|
|
|
|
396,600 |
|
Roche Holding AG1 Non-voting equity securities |
|
|
61,722,809 |
|
12.23 |
% |
|
|
Worldwide pharmaceutical company. (Cost $12,550,849) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
108,265,164 |
|
21.46 |
% |
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited) (continued) |
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks (continued) |
|
|
|
|
|
|
Real Estate & Infrastructure 0.15% |
|
|
|
|
|
|
|
|
|
|
12,000 |
|
Orascom Development Holding AG2 |
|
$ |
758,261 |
|
0.15 |
% |
|
|
Through its subsidiary, offers real estate, infrastructure, and leisure services. (Cost $1,925,937) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
758,261 |
|
0.15 |
% |
|
|
|
Retailers 1.72% |
|
|
|
|
|
|
|
|
|
|
17,550 |
|
Galenica AG1 Registered Shares |
|
|
6,229,565 |
|
1.24 |
% |
|
|
Manufactures and distributes prescription and over-the-counter drugs, toiletries and hygiene products. (Cost $2,147,767) |
|
|
|
|
|
|
|
|
|
|
1,100 |
|
Jelmoli Holding AG Bearer Shares |
|
|
2,431,037 |
|
0.48 |
% |
|
|
Owns and operates department and retail stores and provides mail-order catalog and real estate leasing services. (Cost $1,779,341) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,660,602 |
|
1.72 |
% |
|
|
|
Technology 1.63% |
|
|
|
|
|
|
|
|
|
|
441,200 |
|
Temenos Group AG2 Registered Shares |
|
|
8,223,929 |
|
1.63 |
% |
|
|
Provides integrated software for the banking sector. (Cost $8,486,650) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,223,929 |
|
1.63 |
% |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
|
Utility Suppliers 10.33% |
|
|
|
|
|
|
|
|
|
|
35,023 |
|
Atel Holding, Ltd. |
|
$ |
17,882,424 |
|
3.54 |
% |
|
|
Generates, transmits and distributes electricity throughout Europe. (Cost $16,949,030) |
|
|
|
|
|
|
|
|
|
|
100,817 |
|
BKW FMB Energie AG Registered Shares |
|
|
10,340,205 |
|
2.05 |
% |
|
|
Produces electricity using nuclear, hydroelectric, solar, biomass and wind energy. (Cost $5,171,057) |
|
|
|
|
|
|
|
|
|
|
28,095 |
|
Centralschweizerische Kraftwerke AG Registered Shares |
|
|
13,330,247 |
|
2.64 |
% |
|
|
Supplies electric power, operates and maintains distribution network facilities, constructs and installs equipment, and offers consulting services
to its clients. (Cost $8,416,552) |
|
|
|
|
|
|
|
|
|
|
1,500 |
|
Electrizitaets-Gesellschaft Laufenburg AG Bearer Shares |
|
|
1,672,241 |
|
0.33 |
% |
|
|
Operates nuclear and hydroelectric generating plants and sells excess power throughout Europe. (Cost $1,970,882) |
|
|
|
|
|
|
|
|
|
|
5,000 |
|
Raetia Energie AG Participation Certificate |
|
|
1,863,991 |
|
0.37 |
% |
|
|
Generates and distributes electric power from its own hydroelectric stations, as well as from outside nuclear power suppliers of electric power.
(Cost $2,035,541) |
|
|
|
|
|
|
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited) (continued) |
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks (continued) |
|
|
|
|
|
Utility Suppliers (continued) |
|
|
|
|
|
|
|
3,110 |
|
Romande Energie Holding SA Registered Shares |
|
$ |
7,045,173 |
|
1.40 |
% |
|
|
Distributes electricity in the Canton of Vaud, provides repair and other electrical services to its customers. (Cost $7,533,642) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52,134,281 |
|
10.33 |
% |
|
|
|
|
|
|
Total Common Stocks (Cost
$238,460,872)* |
|
|
421,403,905 |
|
83.51 |
% |
|
|
|
Private Equity Investments3 0.84% |
|
|
|
|
|
|
|
|
|
|
|
|
Aravis Venture II Limited Partnership (471,900 Euro)2,3,4 |
|
|
662,855 |
|
0.13 |
% |
|
|
|
|
|
|
Zurmont Madison Private Equity, Limited Partnership (3,996,768 CHF)2,3,4 |
|
|
3,564,564 |
|
0.71 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Private Equity Investments (Cost $4,467,945) |
|
|
4,227,419 |
|
0.84 |
% |
|
|
|
Call Warrants 0.09% |
|
|
|
|
|
|
|
|
|
|
1,250,000 |
|
Galenica AG Expires 12/19/08 at 400.00 CHF |
|
|
167,224 |
|
0.03 |
% |
|
|
|
|
5,000,000 |
|
Novartis AG Expires 10/17/08 at 60.00 CHF |
|
|
312,152 |
|
0.06 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Call Warrants (Cost $1,642,807) |
|
|
479,376 |
|
0.09 |
% |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
|
Put Warrants 2.04% |
|
|
|
|
|
|
|
|
|
|
10,870,000 |
|
SMIM Price Index Expires 12/19/08 at 250.00 CHF |
|
$ |
3,296,143 |
|
0.66 |
% |
|
|
|
|
2,200,000 |
|
SMIM Price Index Expires 12/19/08 at 300.00 CHF |
|
|
706,354 |
|
0.14 |
% |
|
|
|
|
12,000,000 |
|
Swiss Leader Index Expires 01/16/09 at 20.00 CHF |
|
|
4,494,983 |
|
0.89 |
% |
|
|
|
|
1,600,000 |
|
Swiss Re Expires 12/19/08 at 55.00 CHF |
|
|
499,443 |
|
0.10 |
% |
|
|
|
|
2,700,000 |
|
Syngenta AG Expires 12/19/08 at 241.00 CHF |
|
|
1,011,371 |
|
0.20 |
% |
|
|
|
|
3,000,000 |
|
Zurich Financial Services AG Expires 12/19/08 at 250.00 CHF |
|
|
267,559 |
|
0.05 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Put Warrants (Cost $8,856,178) |
|
|
10,275,853 |
|
2.04 |
% |
|
|
|
|
|
|
Total Investments (Cost $253,427,802)* |
|
|
436,386,553 |
|
86.48 |
% |
|
|
|
|
|
|
Other Assets less Other Liabilities, net |
|
|
68,217,946 |
|
13.52 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Assets |
|
$ |
504,604,499 |
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
1 |
One of the ten largest portfolio holdings. |
2 |
Non-income producing security. |
3 |
Private equity investments are priced at fair value as determined by the Boards valuation committee. At the end
of the period, the value of these securities amounted to $4,227,419 or 0.84% of net assets. |
4 |
Restricted security not registered under the Securities Act of 1933 other than Rule 144A securities. At the end of
the period the value of these securities amounted to $4,227,419 or 0.84% of net assets. Additional information on restricted securities is as follows: |
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited) (continued) |
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
Security |
|
Acquisition Date |
|
Acquisition Cost |
|
Acquisition Value per unit |
Aravis Venture II, LP |
|
July 31, 2007 |
|
$ |
205,328 |
|
$ |
1.00 |
Aravis Venture II, LP |
|
February 21, 2008 |
|
|
399,343 |
|
|
1.00 |
Aravis Venture II, LP |
|
August 4, 2008 |
|
|
81,013 |
|
|
1.00 |
Zurmont Madison Private Equity, LP |
|
September 13, 2007 |
|
|
123,646 |
|
|
1.00 |
Zurmont Madison Private Equity, LP |
|
December 17, 2007 |
|
|
109,210 |
|
|
1.00 |
Zurmont Madison Private Equity, LP |
|
February 28, 2008 |
|
|
3,225,332 |
|
|
1.00 |
Zurmont Madison Private Equity, LP |
|
April 14, 2008 |
|
|
169,431 |
|
|
1.00 |
Zurmont Madison Private Equity, LP |
|
June 26, 2008 |
|
|
154,642 |
|
|
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
4,467,945 |
|
|
|
|
|
|
|
|
|
|
|
|
* |
Cost for Federal income tax purposes is $253,427,802 and net unrealized appreciation (depreciation) consists of: |
|
|
|
|
|
Gross Unrealized Appreciation |
|
$ |
194,951,403 |
|
Gross Unrealized Depreciation |
|
|
(11,992,652 |
) |
|
|
|
|
|
Net Unrealized Appreciation |
|
$ |
182,958,751 |
|
|
|
|
|
|
In September 2006, the Financial Accounting Standards Board issued Statement of Financial
Accounting Standards No. 157, Fair Value Measurements (SFAS 157.) This standard establishes a single authoritative definition of fair value, sets out a framework for measuring fair value, and requires additional
disclosures about fair value measurements. SFAS 157 applies to fair value measurements already required or permitted by existing standards. SFAS 157 is effective for financial statements issued for fiscal years beginning after November 15,
2007, and interim periods within those fiscal years. The changes to current GAAP from the application of this Statement relate to the definition of fair value, the methods used to measure fair value, and the expanded disclosures about fair value
measurements.
One key component of the implementation of SFAS 157 includes the development of a three-tier fair value hierarchy. The
basis of the tiers is dependant upon the various inputs used to determine the value of the Funds investments. These inputs are summarized in the three broad levels listed below:
Level 1quoted prices in active markets for identical assets
Level 2other significant inputs (including quoted prices of similar securities, interest rates, prepayments speeds, credit risk, etc.)
Level 3significant unobservable inputs (including the Funds own assumptions in determining the fair value of investments)
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those
securities.
The following is a summary of the inputs used to value the Funds net assets as of September 30, 2008:
|
|
|
|
Valuation Inputs |
|
Investments in Securities |
Level 1Quoted Prices |
|
$ |
421,403,905 |
Level 2Other Significant Observable Inputs |
|
|
10,755,229 |
Level 3Significant Unobservable |
|
|
4,227,419 |
|
|
|
|
Total Investments |
|
$ |
436,386,553 |
|
|
|
|
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited) (concluded) |
|
September 30, 2008 |
The following is a reconciliation
of Level 3 assets (at either the beginning or the ending of the period) for which significant unobservable inputs were used to determine fair value.
|
|
|
|
|
|
|
Investments in Securities |
|
Balance as of 12/31/2007 |
|
$ |
1,230,949 |
|
Accrued Accretion / (Amortization) |
|
|
|
|
Change in Unrealized Appreciation / (Depreciation) |
|
|
(176,868 |
) |
Net Purchase / (Sales) |
|
|
3,173,338 |
|
Transfers In / (Out) of Level 3 |
|
|
|
|
|
|
|
|
|
Balance as of 9/30/2008 |
|
$ |
4,227,419 |
|
|
|
|
|
|
THE PORTFOLIO OF INVESTMENTS SHOULD BE READ IN CONJUNCTION WITH THE FINANCIAL STATEMENTS AND NOTES TO FINANCIAL
STATEMENTS WHICH ARE INCLUDED IN THE FUNDS AUDITED ANNUAL REPORT OR SEMI-ANNUAL REPORT. THESE REPORTS INCLUDE ADDITIONAL INFORMATION ABOUT THE FUNDS SECURITY VALUATION POLICIES AND ABOUT CERTAIN SECURITY TYPES INVESTED IN BY THE FUND.
Item 2. Controls and Procedures.
(a) |
The registrants President and Treasurer have concluded, based on their evaluation of the registrants disclosure controls and
procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the Act)) as conducted within 90 days of the filing date of this report, that these disclosure controls and procedures are adequately designed and
are operating effectively to ensure that information required to be disclosed by the registrant on Form N-Q is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commissions rules and
forms. |
(b) |
There were no changes in the registrants internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the
registrants most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the registrants internal control over financial reporting. |
Item 3. Exhibits.
Certifications pursuant to Rule 30a-2(a) are
attached hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
|
|
(Registrant) |
|
The Swiss Helvetia Fund, Inc. |
|
|
|
|
|
By (Signature and Title)* |
|
/s/ Rodolphe E. Hottinger |
|
|
|
|
Rodolphe E. Hottinger, Chief Executive Officer |
|
|
Date 11/25/08
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates
indicated.
|
|
|
|
|
By (Signature and Title)* |
|
/s/ Rodolphe E. Hottinger |
|
|
|
|
Rodolphe E. Hottinger, Chief Executive Officer |
|
|
Date 11/25/08
|
|
|
|
|
|
|
|
By (Signature and Title)* |
|
/s/ Rudolf Millisits |
|
|
|
|
Rudolf Millisits, Chief Financial Officer |
|
|
Date 11/26/08